Document is current
Any future updates will be listed below
-
Authors
El Khoury, Louis Y.
Pan, Xiaoyu
Hlady, Ryan A.
Wagner, Ryan T.
Shaikh, Shafiq
Wang, Liguo
Humphreys, Mitchell R.
Castle, Erik P.
Stanton, Melissa L.
Ho, Thai H.
Robertson, Keith D.
-
Funding
Funding for this research was provided by:
National Institute of Health (R01 CA224917, R01 CA224917)
- License Information
-
More Information
Article History
Received: 9 December 2022
Accepted: 21 March 2023
First Online: 29 April 2023
Declarations
:
: This study was approved by Mayo Clinic’s Institutional Review Board. Participants were previously consented by the Mayo Clinic Nephrectomy Registry.
: Not applicable.
: THH: Advisory board participation: Surface Therapeutics, Exelixis, Genentech, Pfizer, Ipsen, Cardinal Health; research support-Novartis. The remaining authors declare no conflict of interest.
